Keyword: FluGen

FluGen heads to PhI with universal flu vax

Nearly a year after raising $12 million to advance its universal flu vaccine candidate into human trials, Madison, WI’s FluGen is heading to the clinic. The company has kicked off a Phase I trial of RedeeFlu, it said in a statement, hoping to take on the challenge of drifted or mismatched flu strains.